論文 - 藤原 一男
-
Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: a Japanese nationwide administrative data study.
Matsumoto Y, Tarasawa K, Misu T, Namatame C, Takai Y, Kuroda K, Fujihara K, Fushimi K, Fujimori K, Aoki M.
Mult Scler Relat Disord. 81 105349 2024年1月
-
Myelin oligodendrocyte glycoprotein antibody-associated disorders: an overview.
Misu T, Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Ono H, Namatame C, Nishiyama S, Fujimori J, Kuroda H, Nakashima I, Fujihara K, Aoki M.
Clin Exp Neuroimmunol. 2023年12月
-
Microfibrillar-associated protein 4 as potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: pathological and clinical aspects.
Samadzadeh S, Olesen MN, Wirenfeldt M, Möller S, Misu T, Soelberg K, Frederiksen JL, Heegaard S, Mariotto S, Fujihara K, Ruprecht K, Andersen TL, Marignier R, Lillevang ST, Flanagan EP, Pittock SJ, Kim HJ, Bennett JL, Friedeman Paul F, Sorensen GL, Weinshenker BG, Lassmann H, Asgari N.
Mult Scler. 29 ( 14 ) 1721 - 1735 2023年10月
-
Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Namatame C, Kuroda H, Misu T, Fujihara K, Aoki M.
Brain. 146 ( 9 ) 3938 - 3948 2023年9月
-
Epidemiology of MOGAD: A review of prevalence and incidence worldwide.
Hor JY, Fujihara K.
Front Neurol. 15 ( 14 ) 1260358 2023年9月
-
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Aktas O, Hartung HP, Smith MA, Rees WA, Fujihara K, Paul F, Marignier R, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Cutter G, She D, Gunsior M, Cimbora D, Katz E, Cree BAC, N-MOmentum study investigators.
J Neurol Neurosurg Psychiatry. 94 ( 9 ) 757 - 768 2023年9月
-
Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study.
Fujihara K, Kim HJ, Saida T, Misu T, Nagano Y, Totsuka N, Iizuka M, Kido S, Terata R, Okumura K, Hirota S, Cree BAC.
Mult Scler Relat Disord. 79 104938 2023年8月
-
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W, Waubant EL, Yamout B, Cohen JA.
Lancet Neurol. 22 ( 8 ) 750 - 768 2023年8月
-
Associations between neuromyelitis optica spectrum disorder, Sjogren's ¨ syndrome, and conditions with electrolyte disturbances.
Akaishi T, Tarasawa K, Matsumoto Y, Sandhya P, Misu T, Fushimie K, Takahashi T, Fujimori J, Ishii T, Fujimori K, Yaegashi N, Nakashima I, Fujihara K, Aoki M.
J Neurol Sci. 452 120742 2023年7月
-
Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Akaishi T, Takahashi T, Misu T, Fujihara K, Nakashima I, Aoki M.
Tohoku J Exp Med. 260 ( 3 ) 215 - 221 2023年7月
-
Pathology of MOGAD: a comparison with MS and AQP4 antibody-positive NMOSD.
Takai Y, Misu T, Fujihara K, Aoki M.
Front Neurol. 21 ( 14 ) 1209749 2023年7月
-
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method.
Gold R, Barnett M, Chan A, Feng H, Fujihara K, Giovannoni G, Motalban X, Shi FD, Tintore M, Xue Q, Yang C, Zhou H.
Ther Adv Neurol Disord. 14 ( 16 ) 2023年7月
-
Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan.
Nakashima I, Nakahara J, Yokote H, Manabe Y, Okamura K, Hasegawa K, Fujihara K.
Ther Adv Neurol Disord. 16 2023年6月
-
Attack adjudication in neuromyelitis optica spectrum disorder: substantiation of criteria by magnetic resonance imaging and biomarkers in N-Momentum.
Weinshenker BG, Wingerchuk DM, Green AJ, Bennett JL, Kim HJ, Pittock SJ, Fujihara K, Paul F, Cutter G, Marignier R, Aktas O, Hartung HP, She D, Smith M, Rees W, Patterson K, Cimbora D, Katz E, Cree BAC, N-MOmentum study investigator.
Mult Scler. 29 ( 8 ) 945 - 955 2023年6月
-
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab.
Paul F, Marignier R, Palace J, Arrambide G, Asgari N, Bennett JL, Cree BAC, De Seze J, Fujihara K, Kim HJ, Hornby R, Huda S, Kissani N, Kleiter I, Kuwabara S, Lana-Peixoto MA, Law L, Leite IS, Pandit L, Pittock SJ, Quan C, Ramanathan S, Rotstein D, Saiz A, Sato DK, Vaknin-Dembinsky A.
Neurol Neuroimmunol Neuroinflamm. 10 ( 4 ) e200124 - e200124 2023年5月
-
White blood cell count profiles in the acute phase of AQP4-IgG seropositive NMOSD and MOG-IgG-associated disease.
Akaishi T, Misu T, Fujihara K, Nakaya K, Nakaya N, Nakamura T, Kogure M, Hatanaka R, Itabashi F, Kanno I, Kaneko K, Takahashi T, Fujimori J, Takai Y, Nishiyama S, Ishii T, Aoki M, Nakashima I, Hozawa A.
Sci Rep. 13 ( 1 ) 6481 - 6481 2023年4月
-
Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): International MOGAD Panel Proposed Criteria.
Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan E, Ramanathan S, Waters P, Tenembaum S, MD, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock S, Fujihara K, Palace J.
Lancet Neurol. 22 ( 3 ) 268 - 282 2023年3月
-
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab.
Bennett JL, Fujihara K, Kim HJ, Marignier R, O’Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, Künzel T, Lekkerkerker AN, Lennon-Chrimes S, Pittock SJ.
Front Neurol. 17 ( 14 ) 1114667 2023年2月
-
Contrast-enhanced double inversion recovery sequence for patients with multiple sclerosis: feasibility of subtraction images between pre- and post-contrast images.
Tomura N, Saginoya T, Sanpei T, Konno T, Fujihara K.
Acta Radiol 64 ( 2 ) 719 - 724 2023年2月
-
A novel association of osmotic demyelination in Sjogren’s syndrome ¨ prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review.
Sandhya P, Akaishi T, Fujihara K, Aoki M.
Mult Scler Relat Disord. 69 104466 2023年1月